Tonghua Golden-Horse Pharmaceutical Industry Co,Ltd., together with its subsidiaries, engages in the research, development, manufacture, and sale of pharmaceutical products in China. Its products covers anti-tumor, microbial, cardiovascular, heat-clearing and detoxification, digestive system, skeletal muscle system, gynecological system, nervous system, and other fields. The company also provides bone peptides, protective chemical medicines, cardiovascular and cerebrovascular chinese patent medicines, heat-clearing and detoxifying medicines, and children's respiratory system chinese patent medicines; and Xiaojin pills, Tian Ranshexiang Xiaojin pills, Xiaokechuan capsules, Jiuwei Qianghuo granules, Bear Bile powder, and Wenweishu tablets to treat glandular hyperplasia, inflammatory diseases, bone trauma and soft tissue injury, and other related diseases. In addition, the company offers bacillus cereus live bacteria capsules, bacillus cereus live bacteria tablets are therapeutic live bacteria microecological preparations to treat enteritis, diarrhea, infantile diarrhea, and intestinal dysfunction. Tonghua Golden-Horse Pharmaceutical Industry Co,Ltd. was founded in 1990 and is based in Tonghua City, China.
Metrics to compare | 000766 | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship Relationship000766PeersSector | |
---|---|---|---|---|
P/E Ratio | 384.1x | −13.7x | −0.6x | |
PEG Ratio | 20.09 | 0.06 | 0.00 | |
Price/Book | 10.0x | 2.9x | 2.6x | |
Price / LTM Sales | 17.0x | 6.7x | 3.3x | |
Upside (Analyst Target) | - | −18.0% | 39.1% | |
Fair Value Upside | Unlock | −23.0% | 4.5% | Unlock |